BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34326654)

  • 1. Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice.
    Li L; Fan S; Zhang W; Li D; Yang Z; Zhuang P; Han J; Guo H; Zhang Y
    J Inflamm Res; 2021; 14():3261-3276. PubMed ID: 34326654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neuroinflammatory effects of Eucommia ulmoides Oliv. In a Parkinson's mouse model through the regulation of p38/JNK-Fosl2 gene expression.
    Fan S; Yin Q; Li D; Ma J; Li L; Chai S; Guo H; Yang Z
    J Ethnopharmacol; 2020 Oct; 260():113016. PubMed ID: 32464317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease.
    Ma C; Liu Y; Li S; Ma C; Huang J; Wen S; Yang S; Wang B
    CNS Neurosci Ther; 2023 Jul; 29(7):2018-2035. PubMed ID: 36914567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.
    Rabaneda-Lombarte N; Serratosa J; Bové J; Vila M; Saura J; Solà C
    J Neuroinflammation; 2021 Apr; 18(1):88. PubMed ID: 33823877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
    Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
    J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chinese herbal medicine Dai-Zong-Fang promotes browning of white adipocytes
    Xu J; Zhang LW; Feng H; Tang Y; Fu SQ; Liu XM; Zhu XY
    Front Pharmacol; 2023; 14():1176443. PubMed ID: 37251344
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D; Fu S; Ye B; Wang H; He Y; Li Z; Li J; Gao X; Liu D
    J Neuroinflammation; 2023 Mar; 20(1):86. PubMed ID: 36991440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
    Panicker N; Saminathan H; Jin H; Neal M; Harischandra DS; Gordon R; Kanthasamy K; Lawana V; Sarkar S; Luo J; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Neurosci; 2015 Jul; 35(27):10058-77. PubMed ID: 26157004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
    Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of DJ-1 Augments Neuroinflammation via Nrf2/Trx1/NLRP3 Axis in MPTP-induced Parkinson's Disease Mouse Model.
    Ji YJ; Wang HL; Yin BL; Ren XY
    Neuroscience; 2020 Aug; 442():253-263. PubMed ID: 32526245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.
    Costa T; Fernandez-Villalba E; Izura V; Lucas-Ochoa AM; Menezes-Filho NJ; Santana RC; de Oliveira MD; Araújo FM; Estrada C; Silva V; Costa SL; Herrero MT
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):390-402. PubMed ID: 32564332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Park JS; Leem YH; Park JE; Kim HS
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):470-482. PubMed ID: 32671618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.